Palisade Capital Management LLC Repligen Corp Transaction History
Palisade Capital Management LLC
- $3.13 Billion
- Q4 2024
A detailed history of Palisade Capital Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Palisade Capital Management LLC holds 260,109 shares of RGEN stock, worth $42.9 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
260,109
Previous 245,455
5.97%
Holding current value
$42.9 Million
Previous $36.5 Million
2.5%
% of portfolio
1.2%
Previous 1.14%
Shares
30 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.25 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.18 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$840 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$279 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$254 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $9.14B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....